Korean J Med.
2010 Jan;78(1):36-48.
Recent advances in the treatment of adults with acute lymphoblastic leukemia
- Affiliations
-
- 1Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
Abstract
- Despite improvements in the achievement of complete remission and progress in the supportive care of adults with acute lymphoblastic leukemia (ALL) during the last decade, the majority of patients have eventually relapsed with overall survival in adult ALL of only 30~40%. However, recent therapeutic advances in allogeneic stem cell transplantation through the conduct of large collaborative studies, better understanding of the relevance of cytogenetics and molecular determinants, improved molecular techniques for the detection of minimal residual disease, and clinical research into novel biologic and targeted therapies have all combined to offer potentially a better hope for an improved outcome in this uncommon and difficult disease. Full knowledge of the molecular features associated with treatment response is required for precise leukemia prognostication and monitoring, and can provide clues to useful targets for novel therapies.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Advances in the Treatment of Childhood Acute Lymphoblastic Leukemia
- Recent Advance in Treatment of Acute Lymphoblastic Leukemia in Childhood
- A Case of Acute Lymphoblastic Leukemia Accompanied with Lactic Acidosis and Kidney Enlargement
- Precursor B-Cell Acute Lymphoblastic Leukemia in Two Patients with a History of Cytotoxic Therapy
- Adolescents and young adults (AYA) with acute lymphoblastic leukemia
